While Eli Lilly and Co. continues to work with a biotech firm on the diabetes medicine Byetta, it’s developing a potential
competitor to Byetta all on its own.
Greenwood-based Elona Biotechnologies said it has created two subsidiaries to boost its biosimilar/biogeneric/follow-on protein
business.
Taking science from the laboratory to the commercial market takes too much time and is littered with potential pitfalls along the way.
In a state steeped in advanced research that spawns biomedical companies by the dozen, Apricity LLC is preposterously low-tech,
given that its latest product is nothing more than a warm blanket.
The Indiana chapter of the Arthritis Foundation works to improve lives through leadership in the prevention, control and cure
of arthritis and related diseases.
Indiana is becoming not only a hotbed of “pharmacogenomics” research, but also a trailblazer in finding practical ways to
use it on the practitioner level.
Purdue University’s Student-Managed Venture Fund is betting its bank on West Lafayette-based biotech startup Kylin Therapeutics
Inc.
The stimulus bill has prompted Indiana businesses and not-for-profits that deal in medical records to look for partners to
help them meet the challenge of making those records electronic in five years.
The Indiana Chamber of Commerce has named Indianapolis-based health care research and testing firm AIT Laboratories its 2009
Small Business of the Year.
In January, St. Paul, Minn.-based 3M will release “Clinpro 5000,” a specialty toothpaste Indiana Nanotech developed.
If Indianapolis is going to be a first-class city, it needs to have a comprehensive smoke-free workplace law.
Nathan’s Battle Foundation, led by Phil Milto–who has two sons afflicted with the disease–has evolved over 10 years into
what Milto calls a not-for-profit biotech company that has raised money and guided research that resulted in a promising treatment
for Batten disease. Now, some of the gene therapy techniques researchers developed are being applied to other disorders.
For the last two months, two academics at Indiana University and Purdue University have been discussing how the institutions
can work together to rev up research in medicine and life sciences and, in the process, boost Indiana’s economy.
When Dr. Jack Farr II saw his grandfather’s knees become bowed out, then saw his father get a knee replacement, he knew he
was next. So he spent his career trying to develop new techniques to replace–and now even regrow–the cartilage around knees.
His labors are part of an international effort to develop alternatives to joint replacements.
